Seres Therapeutics Inc. (MCRB)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	126.33M	7.13M	144.93M	33.22M	34.51M	28.27M	32.10M	21.77M	-	-	-	-
Cost of Revenue	704.00K	1.00M	1.73M	90.57M	80.14M	95.95M	89.45M	81.99M	728.00K	10.72M	-	-
Gross Profit	125.62M	6.12M	143.19M	-57.35M	-45.64M	-67.69M	-57.35M	-60.22M	-728.00K	-10.72M	-	-
Operating Income	-107.98M	-246.49M	-64.49M	-88.13M	-71.88M	-100.28M	-91.39M	-92.84M	-54.86M	-15.08M	-6.05M	-3.03M
Interest Income	7.30M	3.06M	2.87M	946.00K	1.03M	-	-	2.23M	638.00K	-	-	-
Pretax Income	-113.72M	-250.16M	-65.58M	-89.13M	-70.28M	-98.94M	-89.38M	-91.58M	-54.78M	-16.71M	-6.10M	-3.13M
Net Income	-113.72M	-253.82M	-61.50M	-86.45M	-64.24M	-98.94M	-89.38M	-91.58M	-54.78M	-16.71M	-6.10M	-3.13M
Selling & General & Admin	87.74M	79.69M	69.26M	30.77M	24.75M	32.60M	34.04M	32.62M	16.76M	4.36M	1.25M	956.00K
Research & Development	145.86M	172.92M	141.89M	90.57M	80.14M	95.95M	89.45M	81.99M	38.09M	10.72M	4.80M	2.08M
Other Expenses	-	1.00M	-1.73M	981.00K	1.07M	170.00K	425.00K	-	-	-	-	-
Operating Expenses	233.60M	253.62M	209.42M	121.34M	104.89M	128.55M	123.50M	114.61M	54.86M	15.08M	6.05M	3.03M
Interest Expense	13.18M	6.02M	2.91M	2.92M	502.00K	1.17M	1.59M	969.00K	555.00K	-	42.00K	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	234.31M	253.62M	209.42M	121.34M	104.89M	128.55M	123.50M	114.61M	54.86M	15.08M	6.05M	3.03M
Income Tax	-	3.67M	-4.08M	-2.67M	-6.04M	1.34M	-1.59M	2.23M	-804.00K	1.63M	42.00K	-
Shares Outstanding (Basic)	128.00M	108.08M	91.70M	79.79M	56.65M	40.74M	40.45M	39.85M	23.53M	29.78M	29.78M	20.68M
Shares Outstanding (Diluted)	128.00M	108.08M	91.70M	79.79M	56.65M	40.74M	40.45M	39.85M	23.53M	29.78M	29.78M	20.68M
EPS (Basic)	-0.89	-2.35	-0.67	-1.08	-1.13	-2.43	-2.21	-2.3	-2.33	-0.56	-0.2	-0.15
EPS (Diluted)	-0.89	-2.35	-0.67	-1.08	-1.13	-2.43	-2.21	-2.3	-2.33	-0.56	-0.2	-0.15
EBITDA	-85.43M	-237.51M	-56.72M	-77.31M	-59.95M	-91.08M	-82.12M	-88.63M	-54.13M	-14.89M	-5.96M	-3.01M
Depreciation & Amortization	6.24M	11.85M	9.22M	8.89M	9.83M	7.86M	7.26M	4.21M	728.00K	190.00K	88.00K	25.00K